Getting Started with CFRT: Membership and the Review Process Explained

Needs Statement

The Child Death Review process reviews all non-natural deaths in their area and identifies gaps in health care or poor social conditions that offer opportunities for change. Reviewing all deaths that qualify can identify trends or rising rates by cause of death or age. Pediatricians are vital members of the CDR teams as they are the experts on child development, age-appropriate behavior and normal physical findings. Pediatricians may not be aware of the Child Death Review process, may not understand their importance in the process, and may not know how to become involved. The purpose of this session is to inform pediatricians of the valuable contributions to individual community health as well as influence important national initiatives to prevent unnecessary childhood deaths they can make by being a member of a Child Death Review team.

Educational Objectives

At the conclusion of this activity, the participants should be able to:

• Describe the significance of the child death review (CDR) process and the pediatrician’s vital role in the process.
• Explain how CDR teams collect data and its application to enhance pediatric practice.
• Analyze local CDR data to understand the impact of sudden unexpected infant death in the community.
• Evaluate how CDR data can be used to influence policy changes and support community and national initiatives in pediatric practice.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

August 1, 2024 through August 31, 2026. Original release date: August 1, 2024.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.